Home › Compare › CXGEF vs ABBV
CXGEF yields 7.80% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, CXGEF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CXGEF + ABBV for your $10,000?
Computer And Technologies Holdings Limited, an investment holding company, provides information technology (IT) solutions for enterprises, multinational corporations, and government organizations in Hong Kong, Mainland China, and internationally. It operates in three segments: Application Services, Solutions and Integration Services, and Investments. The Application Services segment primarily provides enterprise applications software and e-business services for enterprises, including the provision of enterprise application software with implementation and ongoing support services; and government electronic trading services, cloud services, and other related value-added services. Its Solutions and Integration Services segment offers IT solutions implementation and application software development; provision of IT and related operation/infrastructure outsourcing services; business process outsourcing services; and IT systems and network infrastructure with related design, implementation, and ongoing support services. The company's Investments segment engages in various types of investing activities, such property investment for rental income and/or for capital appreciation, and treasury investment in securities. The company also provides system and network integration services; computer support and programming services; products, solutions, and consulting services for cyber intelligence and security; enterprise information management, retail management, and procurement management software products; and human resources management services, as well as sale of computer networks and system platforms, provision of training, and implementation and maintenance of software services. Computer And Technologies Holdings Limited was founded in 1991 and is headquartered in Hong Kong, Hong Kong.
Full CXGEF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.